Teena Bajaj • UCSF Profiles

Teena Bajaj, PhD

Title(s)	Postdoctoral Scholar, Radiation Oncology
School	School of Medicine
Address	1600 Divisadero, #383 San Francisco CA 94115
Pronouns	She/Her/Hers
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Crystal structure of the kinase domain of a receptor tyrosine kinase from a choanoflagellate, Monosiga brevicollis. PLoS One. 2023; 18(6):e0276413. Bajaj T, Kuriyan J, Gee CL. PMID: 37310965; PMCID: PMC10263333.

View in: PubMed Mentions: 3 Fields:
Med Medicine (General)Sci Science
Translation:Humans Animals Cells
Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication. RSC Adv. 2023 Jun 09; 13(26):17667-17677. Bajaj T, Wehri E, Suryawanshi RK, King E, Pardeshi KS, Behrouzi K, Khodabakhshi Z, Schulze-Gahmen U, Kumar GR, Mofrad MRK, Nomura DK, Ott M, Schaletzky J, Murthy N. PMID: 37312993; PMCID: PMC10259201.

View in: PubMed Mentions: 1
A covalent inhibitor targeting the papain-like protease from SARS-CoV-2 inhibits viral replication. RSC Adv. 2023 Apr 03; 13(16):10636-10641. Han H, Gracia AV, Røise JJ, Boike L, Leon K, Schulze-Gahmen U, Stentzel MR, Bajaj T, Chen D, Li IC, He M, Behrouzi K, Khodabakhshi Z, Nomura DK, Mofrad MRK, Kumar GR, Ott M, Murthy N. PMID: 37025664; PMCID: PMC10072198.

View in: PubMed Mentions:
Meta-Analysis of the Expansion in the Field of Structural Biology of ABC Transporters. Biodes Res. 2022; 2022:9806979. Kim S, Bajaj T, Chabon C, Tablante E, Kulchinskaya T, Moon TS, Bajaj R. PMID: 37850125; PMCID: PMC10521687.

View in: PubMed Mentions:
Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2. ACS Infect Dis. 2021 08 13; 7(8):2337-2351. Biering SB, Van Dis E, Wehri E, Yamashiro LH, Nguyenla X, Dugast-Darzacq C, Graham TGW, Stroumza JR, Golovkine GR, Roberts AW, Fines DM, Spradlin JN, Ward CC, Bajaj T, Dovala D, Schulze-Gamen U, Bajaj R, Fox DM, Ott M, Murthy N, Nomura DK, Schaletzky J, Stanley SA. PMID: 34129317.

View in: PubMed Mentions: 20 Fields:
Ant Anti-Infective Agents Dru Drug Therapy Mic Microbiology
Translation:Humans Cells PHPublic Health
Elevated Serum SIRT 2 May Differentiate Parkinson's Disease From Atypical Parkinsonian Syndromes. Front Mol Neurosci. 2019; 12:129. Singh AP, Ramana G, Bajaj T, Singh V, Dwivedi S, Behari M, Dey AB, Dey S. PMID: 31244600; PMCID: PMC6581755.

View in: PubMed Mentions: 8
Serum Mortalin Correlated with α-Synuclein as Serum Markers in Parkinson's Disease: A Pilot Study. Neuromolecular Med. 2018 03; 20(1):83-89. Singh AP, Bajaj T, Gupta D, Singh SB, Chakrawarty A, Goyal V, Dey AB, Dey S. PMID: 29307058.

View in: PubMed Mentions: 6 Fields:
Mol Molecular Biology Neu Neurology
Translation:Humans